Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Evolent Health, Inc. stock logo
EVH
Evolent Health
$8.27
-2.2%
$8.94
$7.06
$33.63
$970.31M0.872.42 million shs812,955 shs
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$7.07
-4.3%
$8.20
$6.08
$19.12
$909.87M1.651.21 million shs1.53 million shs
Radware Ltd. stock logo
RDWR
Radware
$26.60
+9.0%
$22.90
$17.01
$27.11
$1.14B0.93222,178 shs890,940 shs
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
$10.91
$10.91
$10.35
$11.93
$283.07M-0.0231,316 shsN/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Evolent Health, Inc. stock logo
EVH
Evolent Health
-2.07%-0.96%-7.96%-12.41%-64.33%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-4.33%-4.72%-11.18%-28.00%-49.72%
Radware Ltd. stock logo
RDWR
Radware
+8.97%+9.56%+12.05%+25.53%+41.87%
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Evolent Health, Inc. stock logo
EVH
Evolent Health
1.6633 of 5 stars
3.51.00.00.02.70.00.6
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
3.8029 of 5 stars
4.25.00.00.01.33.30.6
Radware Ltd. stock logo
RDWR
Radware
1.8925 of 5 stars
1.23.00.00.02.73.31.9
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Evolent Health, Inc. stock logo
EVH
Evolent Health
3.00
Buy$17.79115.19% Upside
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2.45
Hold$13.8395.66% Upside
Radware Ltd. stock logo
RDWR
Radware
2.33
Hold$27.001.50% Upside
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest SHAP, EVH, NEO, and RDWR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2025
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral
5/13/2025
Evolent Health, Inc. stock logo
EVH
Evolent Health
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
5/9/2025
Evolent Health, Inc. stock logo
EVH
Evolent Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$14.00 ➝ $15.00
5/6/2025
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$18.00 ➝ $12.00
5/1/2025
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$17.00 ➝ $10.00
4/30/2025
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/30/2025
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $10.00
4/30/2025
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform$25.00 ➝ $9.00
4/29/2025
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $8.50
4/28/2025
Evolent Health, Inc. stock logo
EVH
Evolent Health
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$13.00 ➝ $13.00
4/17/2025
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$17.00 ➝ $15.00
(Data available from 6/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Evolent Health, Inc. stock logo
EVH
Evolent Health
$2.40B0.40$1.38 per share6.00$9.38 per share0.88
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$672.36M1.35$0.26 per share27.03$7.02 per share1.01
Radware Ltd. stock logo
RDWR
Radware
$281.87M4.03$0.64 per share41.76$8.50 per share3.13
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
N/AN/AN/AN/A($0.47) per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Evolent Health, Inc. stock logo
EVH
Evolent Health
-$113.04M-$1.23N/AN/AN/A-2.41%5.73%2.36%8/6/2025 (Estimated)
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-$87.97M-$0.61N/A78.56N/A-11.92%-2.10%-1.17%8/4/2025 (Estimated)
Radware Ltd. stock logo
RDWR
Radware
$6.04M$0.27190.0173.89N/A2.20%3.81%2.16%7/30/2025 (Estimated)
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
$4.35MN/A0.00N/AN/A-22.17%6.72%N/A

Latest SHAP, EVH, NEO, and RDWR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Evolent Health, Inc. stock logo
EVH
Evolent Health
$0.08$0.06-$0.02-$0.63$460.15 million$483.65 million
5/7/2025Q1 2025
Radware Ltd. stock logo
RDWR
Radware
$0.23$0.27+$0.04$0.10$70.56 million$72.08 million
4/29/2025Q1 2025
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-$0.02-$0.08-$0.06-$0.20$171.38 million$168.04 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Evolent Health, Inc. stock logo
EVH
Evolent Health
N/AN/AN/AN/AN/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
N/AN/AN/AN/AN/A
Radware Ltd. stock logo
RDWR
Radware
N/AN/AN/AN/AN/A
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Evolent Health, Inc. stock logo
EVH
Evolent Health
0.58
1.04
1.04
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
0.38
1.98
1.91
Radware Ltd. stock logo
RDWR
Radware
N/A
1.90
1.82
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
N/A
6.19
6.19

Institutional Ownership

CompanyInstitutional Ownership
Evolent Health, Inc. stock logo
EVH
Evolent Health
N/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
98.50%
Radware Ltd. stock logo
RDWR
Radware
73.12%
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
9.94%

Insider Ownership

CompanyInsider Ownership
Evolent Health, Inc. stock logo
EVH
Evolent Health
1.40%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2.40%
Radware Ltd. stock logo
RDWR
Radware
21.58%
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
58.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Evolent Health, Inc. stock logo
EVH
Evolent Health
5,100117.40 million114.70 millionOptionable
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2,100128.70 million126.79 millionOptionable
Radware Ltd. stock logo
RDWR
Radware
1,14042.69 million32.93 millionOptionable
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
N/A25.95 million10.79 millionNot Optionable

Recent News About These Companies

Senior journalist Kandula Subramaniam passes away
Launch One Acquisition Corp. Cl A
Global borrowing blitz led by blue chips selling $43bn
Launch One Acquisition Corp. - Ordinary Shares - Class A
Boost for Rachel Reeves as borrowing costs fall

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Evolent Health stock logo

Evolent Health NYSE:EVH

$8.26 -0.19 (-2.19%)
Closing price 06/13/2025 03:59 PM Eastern
Extended Trading
$8.27 +0.00 (+0.06%)
As of 06/13/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

NeoGenomics stock logo

NeoGenomics NASDAQ:NEO

$7.07 -0.32 (-4.33%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$7.06 0.00 (-0.07%)
As of 06/13/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

Radware stock logo

Radware NASDAQ:RDWR

$26.60 +2.19 (+8.97%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$26.60 +0.00 (+0.02%)
As of 06/13/2025 06:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Radware Ltd., together with its subsidiaries, develops, manufactures, and markets cyber security and application delivery solutions for cloud, on-premises, and software defined data centers worldwide. The company operates in two segments, Radware's Core Business and The Hawks' Business. It offers DefensePro provides automated DDoS protection; Radware Kubernetes, a web application firewall solution; and Cyber Controller, a unified solution for management, configuration, and attack lifecycle. The company also provides Alteon, an application delivery and security solution that manages application traffic across cloud and data center locations for optimizing availability and performance; and LinkProof NG, a multi-homing and enterprise gateway solution. In addition, it offers ERT Security Updates Subscription that provides protection from network elements, hosts, and applications; ERT Active Attackers Feed, a threat intelligence feed to protect against DDoS threats; ERT Protection Packages; Alteon Global Elastic License, a purchasing and deployment subscription; MSSP Portal, a DDoS detection and mitigation service portal; Location-based Mitigation that enables network traffic based on the geolocation mapping of IP subnets; and Cloud DDoS Protection Service, which offers a range of enterprise-grade DDoS protection services in the cloud. Further, the company provides Cloud Web DDoS Protection, Cloud WAF Service, Bot Manager, Cloud-Native Protector, and Cloud Application Protection Services, as well as technical support, professional, managed, and training and certification services. It sells its products primarily to independent distributors, including value added resellers, original equipment manufacturers, and system integrators. The company was founded in 1996 and is headquartered in Tel Aviv, Israel.

Spree Acquisition Corp. 1 stock logo

Spree Acquisition Corp. 1 NYSE:SHAP

$10.91 0.00 (0.00%)
As of 06/12/2025

Spree Acquisition Corp. 1 Limited does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the mobility-related technology businesses. The company was incorporated in 2021 and is based in Atlanta, Georgia.